Targeted antisense oligonucleotide therapy rescues PRPF31 expression in retinitis pigmentosa caused by a splicing mutation
Molecular Therapy
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Targeted antisense oligonucleotide therapy rescues PRPF31 expression in retinitis pigmentosa caused by a splicing mutation. // Molecular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S1525001626004788?dgcid=rss_sd_all
Targeted antisense oligonucleotide therapy rescues PRPF31 expression in retinitis pigmentosa caused by a splicing mutation. Molecular Therapy. https://www.sciencedirect.com/science/article/pii/S1525001626004788?dgcid=rss_sd_all
“Targeted antisense oligonucleotide therapy rescues PRPF31 expression in retinitis pigmentosa caused by a splicing mutation.” Molecular Therapy.
@article{article117406,
title = {Targeted antisense oligonucleotide therapy rescues PRPF31 expression in retinitis pigmentosa caused by a splicing mutation},
journal = {Molecular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S1525001626004788?dgcid=rss_sd_all}
}